BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pseudomonas infection
,
Adipose tissue
,
Metabolism of nitric oxide
,
Trichostatin A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
GATA3_01
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Spleen
Coronary artery
Urethra
Ileum mucosa
Vagina
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Vesicular stomatitis Indiana virus disease
Periodontitis
Barrett's esophagus
Alpha-1-antitrypsin deficiency
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
OTS-167
CGP 60474
flavopiridol
A 443654
BMS 387032
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PCDH11X
FUBP3
PPP2R2C
NR5A1
MIR122
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Follicular fluid miRNA profiles during the development of the oocyte
Lung adenocarcinoma and adjacent normal tissue miRNA expression profiles
Tumor formation by ATG5 KO cells
Glomerulonephrotic and healthy tissue from C57BL6.MRLc1 congenic mice
PBMC microRNA expression from pulmonary tuberculosis and sarcoidosis patients
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for GATA3_01
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid T…
The Effect of Vitamin A on Atherosclerosis
RAPA-501 Therapy for ALS Expanded Access Protocol
Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR
RAPA-501 Therapy for ALS
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ